Dextrose Injection
Product Images NDC 0338-0172

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0338-0172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Assembly 1 (Image 01)

An instructional diagram showing the assembly of a drug vial, including the vial cover, closure, and drug vial. It notes vial cover sizes of 13mm or 20mm. Instructions below advise removing the vial cover and disinfecting the stopper.*

FDA Label Image

Assembly Step 2 (Image 02)

Illustration showing a Mini-Bag Plus Container used for intravenous injection. The diagram labels components including the bag, breakaway seal inside the port tube, drug vial adaptor, foil cover, administration port, and port protector. Instructions note to peel off the foil cover, to use an adaptor for moisture, and to discard if found damaged.*

FDA Label Image

Assembly Part 3 (Image 03)

An instructional diagram showing how to place a vial upright, hold it firmly, and push the adaptor down until the vial snaps in place. The illustration depicts the vial beneath an adaptor with directional arrows and instructions emphasizing not to twist during the process.*

FDA Label Image

Reconstitution Step 4 (Image 04)

An instructional diagram illustrating the reconstitution process for a drug vial and bag. It shows hands squeezing a bag while holding a vial, demonstrating how to connect and break the vial seal by fully bending it back and forth. Additional text explains checking the vial's safety seal, using only dry vials, and observing a breakaway seal during the procedure.*

FDA Label Image

Reconstitution Step 5 (Image 05)

An instructional diagram showing a hand holding an injection bag with two connectors attached. Below the image, text gives instructions for preparing liquid and powdered drug vials, including holding the bag vial down, squeezing solution into vial until half full, and shaking to suspend the drug in solution.*

FDA Label Image

Reconstitution Step 6 (Image 06)

An instructional illustration demonstrating how to mix Dextrose injection by holding the bag with the vial upside down and squeezing the bag to transfer air into the vial. It includes step-by-step instructions to release and drain the drug from the vial into the bag and to mix the solution thoroughly before use.*

FDA Label Image

Dextrose Hydrous Structural Formula (Image 07)

Chemical structure of dextrose monohydrate (Dextrose Hydrous, USP), showing the detailed molecular arrangement including the glucose ring and associated hydroxyl groups with water of hydration.*

FDA Label Image

Representative Container 0338-0170-01 (Image 08)

Label for Dextrose 5% Injection USP in a 50 mL mini-bag plus single dose container. It contains 2.5 g dextrose monohydrate per 50 mL solution. The label shows directions for use with a 13 mm vial and includes cautions about admixing and storage. Manufactured by Baxter Healthcare Company, Deerfield, IL, made in Ireland.*

FDA Label Image

Representative Container Label 0338-0174-01 (Image 09)

Label for Dextrose 5% Injection USP in a 50 mL mini-bag single-dose container. The label states each 50 mL contains 2.5 g dextrose monohydrate and indicates use with a 20 mm vial. Manufactured by Baxter Healthcare Corporation, Deerfield, IL. The label includes warnings about mixing and storage, along with lot and expiration date fields.*

FDA Label Image

Representative Container Label 0338-0172-01 (Image 10)

Label for 5% Dextrose Injection USP in a 100 mL mini-bag plus single dose container by Baxter Healthcare Company. The label specifies it is for intravenous use with a 13mm vial. It includes usage instructions, storage conditions, and manufacturing information from Baxter Healthcare Corporation, Deerfield, IL, USA, made in Ireland.*

FDA Label Image

Representative Container Label 0338-0176-01 (Image 11)

Label for 100 mL 5% Dextrose Injection USP Mini-Bag Plus single-dose container by Baxter Healthcare Company. It contains 5 g dextrose monohydrate per 100 mL for intravenous use with a 20 mL vial. The label includes handling instructions and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.